Broniarczyk-Loba Anna, Laudańska-Olszewska Iwona, Nowakowska Olimpia
Z Przyklinicznej Poradni Leczenia Zeza Kliniki Chorób Oczu Katedry Chorób Oczu Uniwersytetu Medycznego w Lodzi.
Klin Oczna. 2005;107(10-12):690-3.
The aim of the study is to evaluate the use of botuline A (BTXA) as a form of treatment for squinting patients with onerous diplopia. Two patients with exotropia and one patient with esotropia had injections of BTX A to the lateral rectus muscles of the affected side. The number of injections ranged from 1 to 2. Two patients went on to have surgery. All patients in our study found that BTX A improved their symptoms of diplopia. We conclude that BTX A has an important role in the treatment of squinting patients with burdensome diplopia.
本研究的目的是评估肉毒杆菌A（BTXA）作为治疗患有严重复视的斜视患者的一种治疗方式的效果。两名外斜视患者和一名内斜视患者在患侧的外直肌注射了BTX A。注射次数为1至2次。两名患者随后接受了手术。我们研究中的所有患者都发现BTX A改善了他们的复视症状。我们得出结论，BTX A在治疗患有严重复视的斜视患者中具有重要作用。
